Andaksin en es it fr

Andaksin Brand names, Andaksin Analogs

Andaksin Brand Names Mixture

  • No information avaliable

Andaksin Chemical_Formula


Andaksin RX_link

No information avaliable

Andaksin fda sheet

Andaksin msds (material safety sheet)

Andaksin Synthesis Reference

No information avaliable

Andaksin Molecular Weight

309.469 g/mol

Andaksin Melting Point

< 25 oC

Andaksin H2O Solubility

Soluble as HCl salt

Andaksin State


Andaksin LogP


Andaksin Dosage Forms

Tablets (oral, 1 mg)

Andaksin Indication

Used for the symptomatic treatment of parkinsonism.

Andaksin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Andaksin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Andaksin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Andaksin Patient Information

Andaksin Organisms Affected

Humans and other mammals